Vera Therapeutics, Inc.
Developing biologic therapies for serious immunological diseases, focusing on IgA Nephropathy.
VERA | US
Overview
Corporate Details
- ISIN(s):
- US92337R1014
- LEI:
- Country:
- United States of America
- Address:
- 2000 SIERRA POINT PARKWAY, SUITE 1200, 94005 BRISBANE
- Website:
- https://veratx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious immunological diseases. The company is dedicated to advancing therapies for conditions with high unmet medical needs, with a particular emphasis on setting a new standard of care in IgA Nephropathy. Its mission is to develop innovative biologic therapeutics that have the potential to significantly improve the lives of patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vera Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vera Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vera Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
